Effect of human immunodeficiency virus infection on serum beta2- microglobulin levels in pregnant women

Obstetrics and Gynecology

Volumn 94, Issue 4, 1999, Pages 537-542

  Bardeguez, Arlene D ^a   Connor, Edward ^a,b   Stephens, Richard ^a,b   Denny, Thomas N ^a,b   Holland, Bart ^a,b   Oleske, James ^a,b  

^a Gynecol Women's Hlth New J ^*  (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN;

ARTICLE; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; PERINATAL CARE; PREGNANCY; PRIORITY JOURNAL; PROTEIN ANALYSIS; REGRESSION ANALYSIS; RISK ASSESSMENT; VIRUS PATHOGENESIS; VIRUS TRANSMISSION;

ADULT; BETA 2-MICROGLOBULIN; FEMALE; HIV INFECTIONS; HUMANS; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 0032847271     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(99)00343-9     Document Type: Article

References (22)

1. Gowda S.D., Stein B.S., Mohagheghpour N., Benike C.J., Engleman E.G. Evidence that T cell activation is required for HIV-1 entry in CD4+ lymphocytes. J Immunol. 142:1989;773-780.
2. Fauci A.S. Host factors and the pathogenesis of HIV-induced disease. Nature. 384:1996;529-534.
3. 2-microglobulin and prediction of progression to AIDS in HIV infection. Lancet. 339:1992;1436-1440.
4. 2-microglobulin levels in mildly symptomatic, HIV type 1 seropositive individuals. J Acquir Immune Defic Syndr. 5:1992;215-221.
5. Gorter R.W., Vranizan K.M., Osmond D.H., Moss A.R. Differences in laboratory values in HIV infection by sex, race, and risk group. AIDS. 6:1992;1341-1347.
6. 2-microglobulin in persons with human immunodeficiency virus infection. J Infect Dis. 167:1993;1259-1260.
7. Fernandez-Cruz E., Desco M., Garcia-Montes M., Longo N., Gonzalez B., Zabay J.M. Immunological and serological markers predictive of progression to AIDS in a cohort of HIV-infected drug users. AIDS. 4:1990;987-994.
8. 2-Microglobulin levels in drug users The influence of risk behavior . AIDS. 5:1991;1021-1024.
9. Hofmann B., Wang Y.X., Cumberland W.G., Detels R., Bozorgmehri M., Fahey J.L. Serum beta 2-microglobulin level increases in HIV infection Relation to seroconversion, CD4 T-cell fall and prognosis . AIDS. 4:1990;207-214.
10. Fahey J.L., Taylor J.M., Detels R., Hofmann B., Melmed R., Nishanian P., et al. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med. 322:1990;166-172.
11. 2-Microglobulin as a predictor of death in HIV-infected women from Kigali, Rwanda. AIDS. 8:1994;963-969.
12. Jacobson M.A., De Gruttola V., Reddy M., Arduino J., Strickland S., Reichman R.C., et al. The predictive value of changes in serologic and cell markers of HIV activity for subsequent clinical outcome in patients with asymptomatic HIV disease treated with zidovudine. AIDS. 9:1995;727-734.
13. AIDS among children - United States, 1996. MMWR. 45:1996;1005-1010.
14. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41(no. RR-17):1-19.
15. Calvelli T., Denny T.N., Paxton H., Gelman R., Kagan J. Guideline for flow cytometric immunophenotyping A report from the National Institute of Allergy and Infectious Diseases, Division of AIDS . Cytometry. 14:1993;702-715.
16. Palumbo P.E., Burchett S. Diagnosis of HIV infection and markers of disease progression in infants. Pizzo P.A., Wilfert C.M. Pediatric AIDS. 1998;67-87 Lippincott Williams & Wilkins, Philadelphia.
17. Mikyas Y., Aziz N., Harawa N., Gorre M., Neagos N., Nogueira M., et al. Immunologic activation during pregnancy Serial measurement of lymphocyte phenotype and serum activation molecules in HIV infected and uninfected women . J Reprod Immunol. 33:1997;157-170.
18. Biggar R.J., Pahwa S., Minkoff H., Mendes H., Willoughby A., Landesman S., et al. Immunosuppression in pregnant women infected with human immunodeficiency virus. Am J Obstet Gynecol. 161:1989;1239-1244.
19. Salazar-Gonzalez J.F., Martinez-Maza O., Nishanian P., Aziz N., Shen L.P., Grosser S., et al. Increased immune activation precedes the inflection point of CD4 T cells and the increased serum virus load in human immunodeficiency virus infection. J Infect Dis. 178:1998;423-430.
20. Bredberg-Raden U., Urassa W., Urassa E., Lyamuya E., Msemo G., Kawo G., et al. Predictive markers for mother-to-child transmission of HIV-1 in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr. 8:1995;182-187.
21. 2-microglobulin, HIV-1 p24 antibody and acid-dissociated HIV-1 p24 antigen levels Predictive markers for vertical transmission of HIV-1 in pregnant Ugandan women . AIDS. 7:1993;1475-1479.
22. 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II . AIDS. 8:1994;923-933.